Charles Webster

• NICE
• Health Technology Assessment…

An Analysis of NICE’s Optimised Decisions from 2015 to 2024

Read more

• Broader value and societal…
• Health Technology Assessment…
• Value-Based Pricing

The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region

Read more

• Health Care Systems
• Health Technology Assessment…
• Prevention
• Vaccines

Socio-Economic Value of Adult Immunisation Programmes

Read more

• Antibiotics
• HTA
• Quality of Life
• Antimicrobial Resistance (AMR)
• Health Technology Assessment…
• Value-Based Pricing

Capturing the Broader Value of Antibiotics

Read more

• Dermatology
• NHS
• Productivity
• UK
• Chronic Diseases

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

Read more